Loading data for POM — first visit, this takes a few seconds.
Pomdoctor Limited (POM)
NasdaqGM: POM
· Echtzeitkurs · USD
0.94
+0.05 (5.62%)
Zum Schluss: Aug 18, 2026, 3:58 PM
Pomdoctor Limited (POM) Stock Price, Analysis & Data
5.62% (1D)
| Geld | 0.11 |
| Marktkapitalisierung | 7.04 Mio |
| Umsatz (TTM) | 399.91 Mio |
| Nettogewinn (TTM) | -212.58 Mio |
| Beta | n/a |
| EPS (ttm) | -6.38 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | -0.11 |
| KUV (TTM) | 0.02 |
| Earnings Date | n/a |
| Brief | 1.01 |
| Volumen | 30,699 |
| Ø Vol. (20D) | 92,150 |
| Eröffnung | 0.92 |
| Vortagesschluss | 0.89 |
| Tagesspanne | 0.85 - 0.95 |
| 52-Wk Range | 0.50 - 115.74 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über POM
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply c...
Branche Pharmaceutical Retailers
Sektor Healthcare
IPO Datum Oct 8, 2025
Mitarbeiter 165
Börse NasdaqGM
Tickersymbol POM
Website https://www.7lk.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Pomdoctor 399.91 Mio, ein Anstieg von 16.74% im Vergleich zum Vorjahr (342.56 Mio). Der Gewinn lag bei -212.58 Mio, ein Anstieg von 48.28 %.
Finanzberichte